Loading clinical trials...
Loading clinical trials...
Phase IV Clinical Trial of Immunogenicity of ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a Population Aged 6 to 23 Months
Conditions
Interventions
MCV4
MCV4
+1 more
Locations
1
China
Wuzhi County Center for Disease Control and Prevention
Jiaozuo, Henan, China
Start Date
September 20, 2023
Primary Completion Date
May 15, 2026
Completion Date
July 15, 2026
Last Updated
March 4, 2026
NCT07203755
NCT07505823
NCT07505836
Lead Sponsor
CanSino Biologics Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions